MyFinsight
Home
Blog
About
Maturities of
available-for-sale investment...
$23,373K
(-41.79%↓ Y/Y)
Net cash provided by
(used in) investing...
$15,322K
(1469.26%↑ Y/Y)
Canceled cashflow
$8,051K
Net change in cash,
cash equivalents and...
$5,842K
(-4.10%↓ Y/Y)
Canceled cashflow
$9,480K
Purchases of
available-for-sale investment...
$7,978K
(-80.66%↓ Y/Y)
Purchases of property and
equipment
$73K
(711.11%↑ Y/Y)
Stock-based compensation
$1,145K
(-53.89%↓ Y/Y)
Amortization of right-of-use
assets
$237K
(-45.77%↓ Y/Y)
Depreciation and
amortization
$168K
(-49.55%↓ Y/Y)
Other receivables
-$59K
(95.23%↑ Y/Y)
Prepaid expenses and
other assets
-$18K
(98.75%↑ Y/Y)
Proceeds from issuance of
common stock through...
$16K
(-79.75%↓ Y/Y)
Net cash used in
operating activities
-$9,351K
(68.10%↑ Y/Y)
Net cash (used in)
provided by financing...
-$129K
(-100.35%↓ Y/Y)
Canceled cashflow
$1,627K
Canceled cashflow
$16K
Consolidated net loss
-$10,310K
(70.04%↑ Y/Y)
Principal paid on finance
lease liabilities
$145K
(-45.08%↓ Y/Y)
Accounts payable and
accrued expenses
-$266K
(-154.85%↓ Y/Y)
Operating lease liability
-$208K
(39.00%↑ Y/Y)
Accretion of discount of
available-for-sale investment...
$146K
(-85.12%↓ Y/Y)
Gain on financing
lease bargain...
$48K
Back
Back
Cash Flow
aTYR PHARMA INC (ATYR)
aTYR PHARMA INC (ATYR)
source: myfinsight.com